Your search returned 4 results.

Results
	1.	All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials. [electronic resource] by McGovern, Paul C Wible, Michele El-Tahtawy, Ahmed Biswas, Pinaki Meyer, R Daniel Producer: 20130930 In: International journal of antimicrobial agents vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50). [electronic resource] by Gao, Feng Johnson, Diane L Ekins, Sean Janiszewski, John Kelly, Kevin G Meyer, R Daniel West, Michael Producer: 20030519 In: Journal of biomolecular screening vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials. [electronic resource] by Bassetti, Matteo McGovern, Paul C Wenisch, Christoph Meyer, R Daniel Yan, Jean Li Wible, Michele Rottinghaus, Scott T Quintana, Alvaro Producer: 20160523 In: International journal of antimicrobial agents vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	HIV prevention trial design in an era of effective pre-exposure prophylaxis. [electronic resource] by Cutrell, Amy Donnell, Deborah Dunn, David T Glidden, David V Grobler, Anneke Hanscom, Brett Stancil, Britt S Meyer, R Daniel Wang, Ronnie Cuffe, Robert L Producer: 20180709 In: HIV clinical trials vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)